Radiotheraphy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology

• 

  Año 2006, Vol. 80, Número 2

  • Bridging gaps in translational radiation oncology

    Jens Overgaard, Jacques Bernier

    págs. 109-111

    

  • Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy

    Daniel Zips, Mechthild Krause, Johann Kummermehr, Michael Baumann, Howard D. Thames

    págs. 112-122

    

  • The prognostic value of pimonidazole and tumour pO₂ in human cervix carcinomas after radiation therapy: A prospective international multi-center study

    Jacob C. Lindegaard, Robin Hunter, Val Gebski, James A. Raleigh, Shu-Chuan Chou, Christina Aquino-Parsons, Marianne Nordsmark, Susan E. Davidson, Catharine West, Jens Overgaard, Hanne Havsteen, Julie Loncaster

    págs. 123-131

    

  • Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer

    Michael Milosevic, Melania Pintilie, Ami Syed, Anthony Fyles, Richard P. Hill, Lee Manchul, Wilfred Levin

    págs. 132-137

    

  • The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy

    Ralph E. Durand, Christina Aquino-Parsons

    págs. 138-142

    

  • Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1

    Vincent Vander Poorten, Karin Haustermans, Barbara Barbé, Alfons Balm, Sandra Nuyts, Adrian C. Begg, Pierre Mahy, Marijke Spaepen, Vincent Gregoire, Harlinde De Schutter

    págs. 143-150

    

  • Combined uptake of [¹⁸F]FDG and [¹⁸F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients

    Felix Holzner, Frank Paulsen, Susanne-Martina Eschmann, Daniela Thorwarth, Markus Alber

    págs. 151-156

    

  • Imaging hypoxia after oxygenation-modification: Comparing [¹⁸F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors

    Johan Bussink, Mariëlle Philippens, Albert J. van der Kogel, Esther G.C. Troost, Otto C. Boerman, Jasper Lok, Johannes H.A.M. Kaanders, Peter Laverman, Wim J.G. Oyen

    págs. 157-164

    

  • Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models

    Jan Alsner, Slavka Lukacova, Michael R. Horsman, Jens Overgaard

    págs. 165-171

    

  • Molecular responses of rectal cancer to preoperative chemoradiation

    Annelies Debucquoy, Karel Geboes, Laurence Goethals, William H. Mc Bride, Sarah Roels, Karin Haustermans

    págs. 172-177

    

  • Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin

    Nils Cordes, Michael Baumann, Iris Eke, Antje Mischkus, Veit Sandfort

    págs. 178-184

    

  • Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases

    Luka Milas, Masashi Koto, Hisanori Ariga, Uma Raju, Kathryn A. Mason, Jessica Pickett, Xueguan Lu, David Valdecanas

    págs. 185-191

    

  • CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors

    Kathryn A. Mason, Hisanori Ariga, Nancy Hunter, Robert Neal, Kian Ang, Luka Milas

    págs. 192-198

    

  • Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling

    Hansjörg Eibl, René Handrick, Amelie Rübel, Heidrun Faltin, Claus Belka, Verena Jendrossek

    págs. 199-206

    

  • Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours

    Gemi Moppi, Stefan R. Vink, Marcel Verheij, Ria Dubbelman, Harry Bartelink, Jan H.M. Schellens, Michel J.X. Hillebrand, Jürgen Engel, Herbert Sindermann, Jos H. Beijnen

    págs. 207-213

    

  • TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy

    Stefan R. Vink, Jannie Borst, Inge Verbrugge, Henning Walczak, Manuela B. Schader, Esther H.J. Wissink, Uta Schaefer, Marcel Verheij

    págs. 214-222

    

  • Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays

    James P. Byrne, Judit P. Banáth, Peggy L. Olive, Susan M. MacPhail, Dmitry Klokov

    págs. 223-229

    

  • Radiation-induced effects on gene expression: An in vivo study on breast cancer

    William Ottestad, Marit Muri Holmen, Hege B.K. Landmark, Stefanie S. Jeffrey, Hilde Johnsen, Gavin Sherlock, Turid Gjertsen, ¿slaug Helland, Anna B. Sætersdal, Jahn M. Nesland, Anne-Lise Børresen-Dale, Olag K. Rodningen, Caroline Frøyland, Lars O. Ottestad

    págs. 230-235

    

  • Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiation

    Ekkehard Dikomey, Oliver Zschenker, Agnieszka Wrona, Kerstin Borgmann, Ingo Meier, Thomas Streichert

    págs. 236-249

    

  • Radiation-induced damage to mouse urothelial barrier

    Jana Jaal, Wolfgang Dörr

    págs. 250-256

    

  • Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy

    Anders N. Pedersen, Lena Specht, Håkan Nyström, Trine Juhler-Nøttrup, Lasse Rye Aarup, Mirjana Josipovi¿, Stine S. Korreman

    págs. 257-262

    

  • Intensity modulated photon and proton therapy for the treatment of head and neck tumors

    Antony Lomax, Marloes Steneker, Uwe Schneider

    págs. 263-267

    

  • Comparison of advanced irradiation techniques with photons for benign intracranial tumours

    E. Vanetti, S. Cora, S. Yartsev, G. Nicolini, A. Fogliata, Glenn Bauman, L. Cozzi, A. Clivio, R. Pellegrini

    págs. 268-273